DJIA 17,140.41 69.19 0.41%
NASDAQ 4,520.50 14.65 0.33%
S&P 500 1,982.52 4.72 0.24%
market minute promo

Biogen Idec (NASDAQ: BIIB)

330.17 0.01 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $330.22 0.02%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $330.23
Previous Close $330.16
Daily Range $327.08 - $331.49
52-Week Range $221.07 - $358.89
Market Cap $78.0B
P/E Ratio 36.73
Dividend (Yield) $0.00 (0.0%)
Volume 364,278
Average Daily Volume 969,240
Current FY EPS $12.66





Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

These Companies Are Saving Money and Sticking You With a Tax Bill

Moving abroad results in lower tax bills for companies, but investors often have to pay capital-gains taxes when their transactions go through.

3 Stocks Reiterated As A Buy: PFE, CELG, BIIB

A Few Reasons Why AbbVie's Momentum Will Continue

Short Sellers Make Moves in Key Biotech Stocks

Tech trouble sparks wave of selling on Wall Street

Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market

Today's Stocks Driving Success For The Drugs Industry

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog

Biogen Idec Offers Growth Investors An Attractive Entry Point

See More BIIB News...

BIIB's Top Competitors

BIIB $330.17 (0.00%)
Current stock: BIIB
AMGN $140.85 (0.56%)
Current stock: AMGN
GILD $106.86 (-0.60%)
Current stock: GILD
$0.00 (0.00%)
Current stock: